Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

First functionalized MRI contrast agent recognizing vascular lesions.

Tatsuhiro Yamamoto1, Kenjiro Ikuta, Keiji Oi

  • 1Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Fukuoka 812-8581, Japan.

Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry
|February 3, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply: New Aspects of Vasospastic Angina: Coronary Adventitial and Perivascular Adipose Tissue Inflammation.

Journal of the American College of Cardiology·2018
Same author

Whole-brain low-intensity pulsed ultrasound therapy markedly improves cognitive dysfunctions in mouse models of dementia - Crucial roles of endothelial nitric oxide synthase.

Brain stimulation·2018
Same author

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

European heart journal·2018
Same author

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

European heart journal·2018
Same author

Life-threatening Hyperkalemia Associated with Axitinib Treatment in Patients with Recurrent Renal Carcinoma.

Internal medicine (Tokyo, Japan)·2018
Same author

Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis.

ESC heart failure·2018

Researchers developed a new magnetic resonance imaging contrast agent that specifically targets and highlights damaged blood vessel linings. This compound combines a sensing molecule with a standard imaging component to improve the detection of vascular injuries. Tests show it successfully binds to injured areas and enhances image clarity, potentially aiding in the diagnosis of cardiovascular conditions.

Area of Science:

  • Medical imaging and EB-DTPA-Gd diagnostic research
  • Vascular medicine and radiology

Background:

Current medical diagnostics often struggle to visualize early-stage damage within blood vessel walls. While standard imaging techniques exist, they frequently lack the sensitivity required to pinpoint localized endothelial injuries. This gap motivated the development of specialized molecular probes designed for enhanced contrast. Prior research has shown that traditional agents often distribute non-specifically throughout the circulatory system. That uncertainty drove the need for compounds capable of selective binding to damaged tissue sites. No prior work had resolved the challenge of combining high-affinity sensing units with effective signal-enhancing complexes. Scientists have long sought methods to improve the resolution of vascular pathology during routine scans. This study addresses the requirement for targeted diagnostic tools in cardiovascular medicine.

Purpose Of The Study:

The aim of this study is to design and synthesize a functionalized magnetic resonance imaging contrast agent for vascular lesions. Researchers sought to create a probe capable of specifically recognizing damaged blood vessel linings. This project addresses the limitation of non-targeted agents that fail to highlight localized endothelial injuries. The team focused on combining a sensing unit with a detection unit to achieve high-resolution imaging. They intended to verify whether the Evans Blue analogue could effectively bind to denuded endothelium. The motivation for this work stems from the need for better diagnostic tools in cardiovascular medicine. Scientists aimed to demonstrate that the agent could decrease proton relaxation times in targeted regions. This study provides a framework for developing future contrast media with enhanced specificity for vascular pathology.

Keywords:
MRI contrast agentendothelium injurymolecular imaginggadolinium complex

Frequently Asked Questions

The agent utilizes an Evans Blue derivative to bind specifically to denuded endothelium, while the Gadolinium-DTPA component reduces water proton relaxation times. This dual-action mechanism allows the probe to localize at injury sites and generate the necessary contrast for T1-weighted magnetic resonance imaging.

The probe incorporates a diethylenetriamine-pentaacetic acid-gadolinium complex, which acts as the detection unit. This specific metal-chelate structure is widely recognized for its ability to enhance signal intensity in standard clinical imaging protocols.

The researchers emphasize that the Evans Blue analogue is necessary for the agent to recognize and adsorb to the vascular endothelium-denuded region. Without this specific sensing unit, the compound would lack the affinity required to distinguish damaged vessel walls from healthy tissue.

Related Experiment Videos

Main Methods:

The review approach involved the design and chemical synthesis of a novel molecular probe. Researchers integrated an Evans Blue analogue to serve as the primary sensing unit for damaged endothelium. They combined this with a Gadolinium-DTPA complex to provide the necessary signal for T1-weighted imaging. The team utilized porcine aorta samples to test the binding capabilities of the synthesized compound. They performed functional assays to verify the adsorption of the agent to denuded vascular regions. The experimental design focused on measuring changes in proton relaxation times within the target tissue. Investigators compared the signal intensity of the agent-treated samples against baseline control conditions. This systematic evaluation confirmed the ability of the probe to facilitate clear visualization of the injured vessel wall.

Main Results:

The strongest finding from the literature shows that the agent successfully recognizes and adsorbs to the endothelium-denuded region of the porcine aorta. This targeted binding allows for the clear visualization of vascular lesions during magnetic resonance imaging. The compound effectively decreases the relaxation time of circumferential water protons in the targeted areas. These results confirm that the sensing unit provides the necessary specificity for identifying damaged vessel linings. The detection unit successfully generates the signal contrast required for T1-weighted imaging protocols. The data demonstrate that the probe remains localized at the site of injury throughout the testing period. Researchers observed a consistent signal enhancement in all treated samples compared to untreated controls. These findings indicate that the agent functions as a reliable tool for identifying vascular pathology.

Conclusions:

The authors demonstrate that their novel compound effectively binds to areas where the vessel lining is removed. This synthesis and implications review confirms that the agent successfully shortens proton relaxation times in targeted regions. The findings suggest that this specific molecular design allows for clear visualization of vascular damage. Researchers propose that the agent serves as a functional tool for identifying injured endothelium. The study provides evidence that the probe remains stable enough to perform its intended diagnostic function. Future clinical applications may benefit from the improved sensitivity offered by this targeted approach. The data indicate that the agent offers a viable pathway for non-invasive vascular lesion assessment. This work highlights the potential for combining sensing and detection units in future contrast media development.

The study employs porcine aorta tissue as a model to evaluate the binding affinity of the agent. This biological substrate provides an accurate representation of the vascular environment, allowing the researchers to confirm that the probe successfully adheres to denuded endothelium.

The researchers measured the relaxation time of circumferential water protons to assess the efficacy of the agent. A decrease in this specific measurement indicates successful binding and signal enhancement, confirming the agent's ability to highlight the targeted vascular lesions.

The authors propose that this compound can be employed as a specialized contrast agent for the imaging of vascular lesions. They suggest that this approach could improve the detection of localized endothelial damage compared to conventional, non-targeted imaging methods.